...
机译:Semaphorin 7a作为多发性硬化症的潜在治疗靶标
Hosp Univ Vall dHebron Serv Neurol Neuroimmunol Ctr Esclerosi Multiple Catalunya Vall dHebron;
Hosp Univ Vall dHebron Serv Neurol Neuroimmunol Ctr Esclerosi Multiple Catalunya Vall dHebron;
Hosp Univ Vall dHebron Serv Neurol Neuroimmunol Ctr Esclerosi Multiple Catalunya Vall dHebron;
Inst Bioengn Catalonia IBEC Mol &
Cellular Neurobiotechnol Parc Cient Barcelona Barcelona Spain;
Hosp Univ Vall dHebron Serv Neurol Neuroimmunol Ctr Esclerosi Multiple Catalunya Vall dHebron;
Hosp Univ Vall dHebron Serv Neurol Neuroimmunol Ctr Esclerosi Multiple Catalunya Vall dHebron;
Hosp Univ Vall dHebron Serv Neurol Neuroimmunol Ctr Esclerosi Multiple Catalunya Vall dHebron;
Inst Bioengn Catalonia IBEC Mol &
Cellular Neurobiotechnol Parc Cient Barcelona Barcelona Spain;
Hosp Univ Vall dHebron Serv Neurol Neuroimmunol Ctr Esclerosi Multiple Catalunya Vall dHebron;
Semaphorin 7A; Experimental autoimmune encephalomyelitis; Multiple sclerosis; Neuroinflammation; Neurodegeneration;
机译:Semaphorin 7a作为多发性硬化症的潜在治疗靶标
机译:Semaphorin 7A作为类风湿关节炎的潜在免疫调节剂和有希望的治疗靶标
机译:通过靶向记忆B细胞多发性硬化症中的潜在生物标志物和治疗性LNCRNA
机译:治疗性代谢组学认为脂肪酸代谢作为治疗多发性硬化的靶标
机译:运动神经元的热休克/应激反应:肌萎缩性侧索硬化症的潜在治疗目标
机译:Semaphorin 7A作为类风湿关节炎的潜在免疫调节剂和有希望的治疗靶标
机译:Semaphorin 7A作为类风湿关节炎的潜在免疫调节剂和有希望的治疗靶标
机译:Nrf2:疾病严重程度的新生物标志物和多发性硬化症治疗干预的靶点。